KELLIE TOTH: Open Payments
NPI 1316029630 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,235 in 179 payments from 22 companies in 2025. Trend: 2023 $3,453 · 2024 $4,736 · 2025 $3,235
Food & beverage: $3,169Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $610 |
| Incyte Corporation | 19 | $399 |
| Novartis Pharmaceuticals Corporation | 20 | $399 |
| ABBVIE INC. | 19 | $348 |
| Lilly USA, LLC | 12 | $203 |
| UCB, Inc. | 10 | $190 |
| LEO Pharma Inc. | 15 | $179 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $174 |
| Galderma Laboratories, L.P. | 7 | $161 |
| Regeneron Healthcare Solutions, Inc. | 6 | $123 |
Products named: TREMFYA, Opzelura, SKYRIZI, COSENTYX, Bimzelx, EBGLYSS, DUPIXENT, NEMLUVIO.
Industry payments across AL — which companies pay providers there.
